Clinical Trial Update: Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 long-term safety study of TA-7284 in patients with Type 2 Diabetes Mellitus, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TA-7284

Snippet

Sponsor: Tanabe Pharma Corporation | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2014-04-28